Immix Biopharma Inc — Dividend History & Yield (NASDAQ:IMMX) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Dividends per share ———— — Dividend yield % ———— — Payout ratio % ———— —

Notizie

Il titolo di Immix Biopharma sale dopo lo status di terapia innovativa FDA

La FDA concede lo status di terapia innovativa al farmaco per l’amiloidosi di ImmixBio

Immix Biopharma stock climbs after FDA grants breakthrough therapy status

FDA grants breakthrough therapy status to ImmixBio’s amyloidosis drug

Immix Biopharma (IMMX) Shares Slip As Investors Focus On Plans To Offer And Sell $750 Million In Securities - Immix Biopharma (NASDAQ:IMMX)

Immix Biopharma: Thesis Playing Out; Thoughts On Valuation And Competition (IMMX)

Il CFO di Immix Biopharma Gabriel Morris acquista azioni per 5.000 dollari

Ilya Rachman, CEO di Immix Biopharma, acquista azioni per $4.975

Immix Biopharma CFO Gabriel Morris buys $5k in shares

Ilya Rachman, Immix Biopharma CEO, buys $4975 in shares

Obiettivo di prezzo di Immix Biopharma alzato a $12 da $8 da H.C. Wainwright

Immix Biopharma stock price target raised to $12 from $8 at H.C. Wainwright